Topics:

Rheumatoid Arthritis

Rheumatoid Arthritis

Analysis of data from clinical trials as TB screening protocols changed shows the value of testing for tuberculosis when treating patients for rheumatoid or psoriatic arthritis or spondyloarthropathies with certolizumab pegol.

Medicare claims data yield up the exact toll of out-of-pocket costs to rheumatoid arthritis patients taking disease-modifying drugs. And an online survey of patients reveals how much they fear losing their DMARD for cost reasons.

What brings patients to your office -- and not the specialty office down the street? Insights in this slideshow.

Numbers in randomized drug trials were too small to amass enough adverse events to settle the issue, but combined they show an increased hypertension risk for the tumor necrosis factor inhibitors used to treat rheumatoid arthritis.

Nearly half of rheumatoid arthritis patients were able to retain remission for 3 months on a 25 mg weekly dose plus methotrexate. Returning to full dose quickly resolved disease for those who flared.

Statin May Put the Brakes on Artery Hardening in AS, RA

Patients with rheumatoid arthritis face an increased risk for acute coronary syndromes, but a popular statin seems to reduce asymptomatic carotid plaques.

More good news for Actemra: rheumatoid arthritis patients can safely transition from the intravenous form of the IL-16 blocker to the injectable version.

Pages

Subscribe to Rheumatoid Arthritis on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.